Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blocking HIV entry.

O V Buzko, K M Shokat

    Nature Structural Biology
    |October 3, 1999
    PubMed
    Summary
    This summary is machine-generated.

    This study explores novel methods to inhibit HIV by targeting its fusion mechanism using unique molecular tools. These findings offer new avenues for developing effective antiviral therapies against the human immunodeficiency virus.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors.

    Oncogene·2013
    Same author

    PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML.

    Leukemia·2008
    Same author

    Chemically targeting the PI3K family.

    Biochemical Society transactions·2007
    Same author

    Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations.

    Proceedings of the National Academy of Sciences of the United States of America·2004
    Same author

    Phage-display evolution of tyrosine kinases with altered nucleotide specificity.

    Biopolymers·2002
    Same author

    Recent advances in chemical approaches to the study of biological systems.

    Annual review of cell and developmental biology·2001
    Same journal

    Fingering nucleic acids: the RNA did it.

    Nature structural biology·2003
    Same journal

    Histone H1.2 as a trigger for apoptosis.

    Nature structural biology·2003
    Same journal

    Tom40: more than just a channel.

    Nature structural biology·2003
    Same journal

    Announcing the worldwide Protein Data Bank.

    Nature structural biology·2003
    Same journal

    Small RNAs come of age.

    Nature structural biology·2003
    Same journal

    Recognition and processing of the origin of transfer DNA by conjugative relaxase TrwC.

    Nature structural biology·2003
    See all related articles

    Area of Science:

    • Virology
    • Drug Discovery
    • Molecular Biology

    Background:

    • The human immunodeficiency virus (HIV) relies on its fusogenic machinery for cell entry and infection.
    • Developing inhibitors that block this fusion process is a critical strategy for HIV therapy.

    Discussion:

    • This research investigates the use of unnatural ligand libraries to disrupt the fusogenic machinery of HIV.
    • The study aims to identify novel compounds that can interfere with essential steps in viral entry.

    Key Insights:

    • Unnatural ligands demonstrate potential in targeting and inhibiting HIV's fusogenic complex.
    • This approach offers a new strategy for developing next-generation antiretroviral drugs.

    Outlook:

  • Further research can explore the optimization of these unnatural ligands for enhanced antiviral activity.
  • This work may lead to the development of new therapeutic interventions against HIV infection.